Literature DB >> 16601494

Pathogenesis of urinary tract infection: an update.

Robert H Mak1, Huey-Ju Kuo.   

Abstract

PURPOSE OF REVIEW: Urinary tract infection is the second most common bacterial infection in children. It may cause renal scarring leading to secondary hypertension and chronic kidney disease. Recent information has greatly improved our understanding of the pathogenesis of urinary tract infection and renal scarring. RECENT
FINDINGS: Urothelium, an anatomical barrier for innate immune responses, expresses toll-like receptors with the capacity to recognize pathogen-associated molecular patterns. Engagement of toll-like receptors can lead to uroepithelial cell activation and production of inflammatory mediators. These include complement proteins, other bactericidal peptides, cytokines, chemokines, defensins and adhesion molecules. The resulting inflammatory infiltrate serves to aid bacterial clearance but can also lead to renal damage. Furthermore, interactions between urinary proteins, such as Tamm-Horsfall protein, and TLR-4 add to the complexity of this defense system. Interindividual variability in cellular response may in part be responsible for variable clinical outcomes. Polymorphisms in a number of candidate genes in this host defense mechanism may be involved in determining those patients who are susceptible to recurrent infections and renal scarring following urinary tract infection.
SUMMARY: Further understanding of the basic molecular mechanisms of urinary tract infection and translating these bench data to the bedside holds the promise of improving diagnosis and therapeutic strategies of treating urinary tract infection and preventing recurrence and renal scarring.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601494     DOI: 10.1097/01.mop.0000193276.39495.0d

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  23 in total

1.  The accuracy and health risks of a voiding cystourethrogram after a febrile urinary tract infection.

Authors:  John David Spencer; Carlton M Bates; John D Mahan; Mary-Lynn Niland; Shannon R Staker; David S Hains; Andrew L Schwaderer
Journal:  J Pediatr Urol       Date:  2010-12-03       Impact factor: 1.830

2.  Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection.

Authors:  T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-03       Impact factor: 3.267

3.  Does the presence of vesicoureteral reflux affect in vitro uropathogenic E. coli growth rate in urine?

Authors:  Alper Soylu; Meral Karaman; Demet Alaygut; Seçil Arslansoyu Çamlar; Mehmet Türkmen; Salih Kavukçu
Journal:  Int Urol Nephrol       Date:  2015-12-17       Impact factor: 2.370

Review 4.  The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections.

Authors:  Brian Becknell; Megan Schober; Lindsey Korbel; John David Spencer
Journal:  Expert Rev Anti Infect Ther       Date:  2014-11-25       Impact factor: 5.091

5.  Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa.

Authors:  Rahul Mittal; Saroj Sharma; Sanjay Chhibber; Kusum Harjai
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

6.  Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.

Authors:  Richard R Kulesus; Karen Diaz-Perez; E Susan Slechta; Danelle S Eto; Matthew A Mulvey
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

7.  TLR-4 polymorphisms and leukocyte TLR-4 expression in febrile UTI and renal scarring.

Authors:  Meral Torun Bayram; Alper Soylu; Halil Ateş; Sefa Kızıldağ; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2013-04-24       Impact factor: 3.714

Review 8.  Genetic risk for recurrent urinary tract infections in humans: a systematic review.

Authors:  M Zaffanello; G Malerba; L Cataldi; F Antoniazzi; M Franchini; E Monti; V Fanos
Journal:  J Biomed Biotechnol       Date:  2010-03-30

9.  Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infections.

Authors:  Luis Miguel Rodríguez; Belén Robles; José Manuel Marugán; Angeles Suárez; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2007-11-27       Impact factor: 3.714

10.  Can postpyelonephritic renal scarring be prevented?

Authors:  Tryggve Nevéus
Journal:  Pediatr Nephrol       Date:  2012-10-20       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.